Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a research report report published on Monday morning. The firm issued a hold rating on the stock.

Separately, Alliance Global Partners reduced their price objective on shares of Aspira Women’s Health from $7.00 to $5.50 and set a “buy” rating for the company in a research note on Wednesday, August 14th.

Aspira Women’s Health Trading Up 6.6 %

NASDAQ:AWH opened at $0.81 on Monday. The firm’s 50 day moving average is $0.83 and its 200 day moving average is $1.27. Aspira Women’s Health has a 12 month low of $0.67 and a 12 month high of $5.65. The stock has a market capitalization of $13.50 million, a PE ratio of -0.68 and a beta of 1.44.

Institutional Investors Weigh In On Aspira Women’s Health

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co bought a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned approximately 0.19% of Aspira Women’s Health at the end of the most recent quarter. 12.19% of the stock is owned by institutional investors and hedge funds.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.